Technical Analysis for LUNG - Pulmonx Corporation

Grade Last Price % Change Price Change
F 6.20 3.33% 0.20
LUNG closed up 3.33 percent on Wednesday, November 20, 2024, on 81 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
Bullish Engulfing Bullish 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Wide Bands Range Expansion 3.33%
Down 3 Days in a Row Weakness 3.33%
Down 4 Days in a Row Weakness 3.33%
Down 5 Days in a Row Weakness 3.33%
Oversold Stochastic Weakness 3.33%
Stochastic Reached Oversold Weakness 1.31%
Wide Bands Range Expansion 1.31%

   Recent Intraday Alerts

Alert Time
Down 2 % about 21 hours ago
Down 1% about 21 hours ago
Down 3% 2 days ago
Fell Below Previous Day's Low 2 days ago
Down 2 % 2 days ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Pulmonx Corporation Description

Pulmonx Corporation, a medical technology company, designs, develops, manufactures, and markets minimally invasive medical devices for the diagnosis and treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console with flow and pressure sensors that are used to assess the presence of collateral ventilation. The company also provides StratX Lung Analysis Platform, a cloud-based quantitative computed tomography analysis service that offers information emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for the treatment with Zephyr Valves. It serves emphysema patients in Europe, the Middle East, Africa, the Asia-Pacific, the United States, and internationally. Pulmonx Corporation was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. The company was incorporated in 1995 and is headquartered in Redwood City, California.


Classification

Sector: Healthcare
Industry: Medical Devices
Keywords: Medicine Clinical Medicine Inflation Medical Technology Catheter Chronic Obstructive Pulmonary Disease Pulmonary Disease Tomography Pulmonology Balloon Catheter Invasive Medical Devices Lung Minimally Invasive Medical Devices

Is LUNG a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 14.835
52 Week Low 5.46
Average Volume 222,057
200-Day Moving Average 7.92
50-Day Moving Average 7.13
20-Day Moving Average 6.68
10-Day Moving Average 6.72
Average True Range 0.44
RSI (14) 41.52
ADX 19.02
+DI 18.76
-DI 28.23
Chandelier Exit (Long, 3 ATRs) 6.49
Chandelier Exit (Short, 3 ATRs) 7.17
Upper Bollinger Bands 7.76
Lower Bollinger Band 5.59
Percent B (%b) 0.28
BandWidth 32.53
MACD Line -0.17
MACD Signal Line -0.08
MACD Histogram -0.0861
Fundamentals Value
Market Cap 237.51 Million
Num Shares 38.3 Million
EPS -1.62
Price-to-Earnings (P/E) Ratio -3.83
Price-to-Sales 8.42
Price-to-Book 4.36
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 6.74
Resistance 3 (R3) 6.69 6.45 6.65
Resistance 2 (R2) 6.45 6.32 6.48 6.62
Resistance 1 (R1) 6.33 6.23 6.39 6.38 6.59
Pivot Point 6.09 6.09 6.13 6.12 6.09
Support 1 (S1) 5.97 5.96 6.03 6.02 5.81
Support 2 (S2) 5.73 5.87 5.76 5.78
Support 3 (S3) 5.61 5.73 5.75
Support 4 (S4) 5.66